Lyell Immunopharma, Inc. - Common Stock (LYEL)

CUSIP: 55083R104

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / Common Stock
Shares outstanding
21,259,732
Total 13F shares
131,309,565
Share change
+532,947
Total reported value
$255,237,592
Put/Call ratio
108%
Price per share
$1.94
Number of holders
116
Value change
+$1,520,026
Number of buys
54
Number of sells
42

Quarterly Holders Quick Answers

What is CUSIP 55083R104?
CUSIP 55083R104 identifies LYEL - Lyell Immunopharma, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of LYEL - Lyell Immunopharma, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
GSK plc
3/4/5
10%+ Owner
class O/S missing
30,253,189
$68,977,271 21 Jun 2021
MWG Management Ltd.
13F
Company
95%
20,162,332
$29,638,628 30 Sep 2023
13F
VANGUARD GROUP INC
13F
Company
80%
16,909,720
$24,857,288 30 Sep 2023
13F
Orland Properties Ltd
13F
Company
71%
15,093,969
$22,188,134 30 Sep 2023
13F
BlackRock Finance, Inc.
13F
Company
63%
13,420,242
$19,727,756 30 Sep 2023
13F
Foresite Capital Management IV, LLC
13F
Company
41%
8,784,813
$12,913,675 30 Sep 2023
13F
STATE STREET CORP
13F
Company
32%
6,810,428
$10,011,329 30 Sep 2023
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
31%
6,686,197
$9,830,000 30 Sep 2023
13F
Alphabet Inc.
13F
Company
28%
5,865,125
$8,621,733 30 Sep 2023
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
17%
3,656,483
$5,375,641 30 Sep 2023
13F
HSG Holding Ltd
13F
Company
14%
3,045,997
$4,477,616 30 Sep 2023
13F
FMR LLC
13F
Company
13%
2,847,426
$4,185,716 30 Sep 2023
13F
MIC Capital Management UK LLP
13F
Company
8.2%
1,740,569
$2,558,636 30 Sep 2023
13F
NORTHERN TRUST CORP
13F
Company
7%
1,483,178
$2,180,271 30 Sep 2023
13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
13F
Company
6.4%
1,363,190
$2,003,889 30 Sep 2023
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
5.9%
1,250,711
$1,838,545 30 Sep 2023
13F
TD ASSET MANAGEMENT INC
13F
Company
4.3%
916,232
$1,346,861 30 Sep 2023
13F
CITADEL ADVISORS LLC
13F
Company
3.5%
747,143
$1,098,300 30 Sep 2023
13F
BAILLIE GIFFORD & CO
13F
Company
3.4%
732,636
$1,076,975 30 Sep 2023
13F
Nuveen Asset Management, LLC
13F
Company
3.4%
731,258
$1,074,950 30 Sep 2023
13F
BANK OF AMERICA CORP /DE/
13F
Company
3.4%
728,097
$1,070,302 30 Sep 2023
13F
Bank of New York Mellon Corp
13F
Company
3.1%
661,561
$972,495 30 Sep 2023
13F
CANADA PENSION PLAN INVESTMENT BOARD
13F
Company
2.8%
588,235
$864,705 30 Sep 2023
13F
GOLDMAN SACHS GROUP INC
13F
Company
2.5%
537,617
$790,297 30 Sep 2023
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
2.2%
464,325
$682,558 30 Sep 2023
13F
Rafferty Asset Management, LLC
13F
Company
2%
424,886
$624,582 30 Sep 2023
13F
Clarius Group, LLC
13F
Company
1.9%
399,168
$586,777 30 Sep 2023
13F
JACOBS LEVY EQUITY MANAGEMENT, INC
13F
Company
1.5%
325,359
$478,278 30 Sep 2023
13F
Invesco Ltd.
13F
Company
1.4%
292,712
$430,287 30 Sep 2023
13F
Swiss National Bank
13F
Company
1.3%
271,700
$399,399 30 Sep 2023
13F
RHUMBLINE ADVISERS
13F
Company
1.3%
268,826
$395,165 30 Sep 2023
13F
MORGAN STANLEY
13F
Company
1.2%
254,940
$374,761 30 Sep 2023
13F
JPMORGAN CHASE & CO
13F
Company
1.2%
254,461
$374,057 30 Sep 2023
13F
BARCLAYS PLC
13F
Company
1.2%
245,243
$360,507 30 Sep 2023
13F
CAXTON ASSOCIATES LP
13F
Company
0.93%
198,477
$291,761 30 Sep 2023
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.93%
196,875
$289,407 30 Sep 2023
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.92%
195,515
$287,407 30 Sep 2023
13F
UBS Group AG
13F
Company
0.92%
195,076
$286,761 30 Sep 2023
13F
CITIGROUP INC
13F
Company
0.91%
193,739
$284,796 30 Sep 2023
13F
SHELL ASSET MANAGEMENT CO
13F
Company
0.88%
187,163
$275,000 30 Sep 2023
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.82%
174,660
$256,750 30 Sep 2023
13F
BBR PARTNERS, LLC
13F
Company
0.77%
164,041
$241,140 30 Sep 2023
13F
NEW YORK LIFE INVESTMENT MANAGEMENT LLC
13F
Company
0.71%
150,866
$221,773 30 Sep 2023
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.7%
148,595
$218,435 30 Sep 2023
13F
CREDIT SUISSE AG/
13F
Company
0.62%
131,040
$192,629 30 Sep 2023
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
0.57%
120,951
$177,798 30 Sep 2023
13F
Legal & General Group Plc
13F
Company
0.57%
121,165
$177,713 30 Sep 2023
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.56%
120,058
$176,485 30 Sep 2023
13F
XTX Topco Ltd
13F
Company
0.54%
114,720
$168,638 30 Sep 2023
13F
STATE OF WISCONSIN INVESTMENT BOARD
13F
Company
0.5%
106,695
$156,842 30 Sep 2023
13F

Institutional Holders of Lyell Immunopharma, Inc. - Common Stock (LYEL) as of Q4 2023

As of 31 Dec 2023, Lyell Immunopharma, Inc. - Common Stock (LYEL) was held by 116 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 131,309,565 shares. The largest 10 holders included MWG Management Ltd., Orland Properties Ltd, BlackRock Inc., VANGUARD GROUP INC, Foresite Capital Management IV, LLC, WuXi AppTec Co., Ltd., PRICE T ROWE ASSOCIATES INC /MD/, Alphabet Inc., GEODE CAPITAL MANAGEMENT, LLC, and STATE STREET CORP. This page lists 116 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders
102
Q4 2023 holders
116
Holder diff
14
Investor Q3 2023 Shares Q4 2023 Shares Share Diff Share Chg % Q3 2023 Value $ Q4 2023 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .